Advanced search
Publication Cover
Risk Management and Healthcare Policy Volume 14, 2021 - Issue
Submit an article Journal homepage
121
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Effect of COVID-19 Pandemic on Diagnosis and Treatment Delays in Urological Disease: Single-Institution Experience

Zhen Li1 Department of Urology, The Fifth People’s Hospital of Dalian, Dalian, Liaoning, People’s Republic of China
,
Yu Jiang2 Department of Pediatrics, Dalian Municipal Women and Children’s Medical Center, Dalian, Liaoning, People’s Republic of China
,
Yang Yu3 Department of Urology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of China
&
Qianyu Kang3 Department of Urology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of ChinaCorrespondence[email protected] [email protected]
Pages 895-900 | Published online: 04 Mar 2021

References

  • Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi:10.1056/NEJMoa2001017
  • Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. doi:10.1056/NEJMoa2002032
  • Puliatti S, Eissa A, Eissa R, et al. COVID-19 and urology: a comprehensive review of the literature. BJU Int. 2020;125:E7–E14. doi:10.1111/bju.15071
  • Ferrara G, De Vincentiis L, Ambrosini-Spaltro A, et al. Cancer diagnostic delay in Northern and Central Italy during the 2020 lockdown due to the Coronavirus Disease 2019 pandemic. Am J Clin Pathol. 2020. doi:10.1093/ajcp/aqaa243
  • Ford ES, Mokdad AH, Link MW, et al. Chronic disease in health emergencies: in the eye of the hurricane. Prev Chronic Dis. 2006;3:A46.
  • Slama S, Kim HJ, Roglic G, et al. Care of non-communicable diseases in emergencies. Lancet. 2017;389:326–330. doi:10.1016/S0140-6736(16)31404-0
  • Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–337. doi:10.1016/S1470-2045(20)30096-6
  • Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol. 2020;6:1108–1110. doi:10.1001/jamaoncol.2020.0980
  • Pawinski A, Sylvester R, Kurth KH, et al. A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer. J Urol. 1996;156:1934–1940, discussion 1940–1931.
  • Sylvester RJ, Oosterlinck W, Witjes JA. The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials. Eur Urol. 2008;53:709–719. doi:10.1016/j.eururo.2008.01.015
  • Lenfant L, Seisen T, Loriot Y, Rouprêt M. Adjustments in the use of intravesical instillations of bacillus calmette-guérin for high-risk non-muscle-invasive bladder cancer during the COVID-19 pandemic. Eur Urol. 2020;78:1–3. doi:10.1016/j.eururo.2020.04.039
  • Wallace DM, Bryan RT, Dunn JA, Begum G, Bathers S. Delay and survival in bladder cancer. BJU Int. 2002;89:868–878. doi:10.1046/j.1464-410X.2002.02776.x
  • Das M. Androgen deprivation therapy for prostate cancer. Lancet Oncol. 2017;18:e567. doi:10.1016/S1470-2045(17)30670-8
  • Liu F, Sun D, Zhou X, et al. Effect of adjuvant hormone therapy in patients with prostate cancer: a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2018;97:e13145. doi:10.1097/MD.0000000000013145
  • Sengupta S, Blute ML, Bagniewski SM, et al. Increasing prostate specific antigen following radical prostatectomy and adjuvant hormonal therapy: doubling time predicts survival. J Urol. 2006;175:1684–1690; discussion 1690. doi:10.1016/S0022-5347(05)00978-X
  • van Tol-geerdink JJ, Leer JW, van Lin EN, Schimmel EC, Stalmeier PF. Depression related to (neo)adjuvant hormonal therapy for prostate cancer. Radiother Oncol. 2011;98:203–206. doi:10.1016/j.radonc.2010.12.006
  • Juanjuan L, Santa-Maria CA, Hongfang F, et al. Patient-reported outcomes of patients with breast cancer during the COVID-19 outbreak in the epicenter of China: a cross-sectional survey study. Clin Breast Cancer. 2020;20:e651–e662. doi:10.1016/j.clbc.2020.06.003
  • Frey MK, Ellis AE, Zeligs K, et al. Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer. Am J Obstet Gynecol. 2020;223:725.e721–725.e729. doi:10.1016/j.ajog.2020.06.049
  • Fauci AS, Lane HC, Redfield RR. Covid-19 - navigating the uncharted. N Engl J Med. 2020;382:1268–1269. doi:10.1056/NEJMe2002387
  • Boehm K, Ziewers S, Brandt MP, et al. Telemedicine online visits in urology during the COVID-19 pandemic-potential, risk factors, and patients’ perspective. Eur Urol. 2020;78:16–20. doi:10.1016/j.eururo.2020.04.055

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.